China’s Fosun is said to consider $500 million IPO of Indian drugmaker Gland Pharma
The share sale could raise about $500 million. Deliberations are at an early stage, and any listing is unlikely to take place before next year, the people said.
from The Financial ExpressThe Financial Express https://ift.tt/2La3Cjh
via IFTTT
from The Financial ExpressThe Financial Express https://ift.tt/2La3Cjh
via IFTTT
Good information. Thanks for sharing.
ReplyDeleteGland Pharma
Spandana Sphoorty IPO
Sterling & Wilson Solar IPO
Spandana Sphoorty Financial Ltd